ESMO 2022: Breaking Down the Phase 3 PIVOT-09 Study

By The Uromigos - Last Updated: September 12, 2022

Nizar Tannir describes this randomized phase 3 study on bempegaldesleukin plus nivolumab as presented at ESMO.

Post Tags:Uromigos-ESMO
Advertisement
Advertisement